For treatment options in patients with PM/DM-ILD, there is evidence that immunosuppressive therapy is effective in the combination of acute progressive ILD in patients with anti-MDA5 antibody-positive CADM. This evidence concerns the gene IFIH1 and interstitial lung disease.